CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia.
Acta Pharmacol Sin
; 43(1): 121-132, 2022 Jan.
Article
in En
| MEDLINE
| ID: mdl-33767379
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Organic Anion Transporters
/
Organic Cation Transport Proteins
/
Hyperuricemia
/
Glucose Transport Proteins, Facilitative
Limits:
Humans
Language:
En
Journal:
Acta Pharmacol Sin
Journal subject:
FARMACOLOGIA
Year:
2022
Type:
Article
Affiliation country:
China